Skip to main content

and
  1. No Access

    Article

    CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms

    CUDC-907 is a promising dual-target inhibitor of the HDAC and PI3K signaling pathways, with demonstrated therapeutic effects in a range of malignant tumors. However, its potential application in ovarian cancer...

    Yuanpei Wang, **g Wen, **angyi Sun, Yi Sun in Cancer Chemotherapy and Pharmacology (2024)

  2. Article

    Open Access

    Comparison of clinical characteristics and prognosis between type I and type II endometrial cancer: a single-center retrospective study

    To explore the differences in clinical characteristics, prognosis, and risk factors between type I and type II endometrial cancer (EC).

    Yuanpei Wang, Yi Sun, Fangfang Sun, Pin Han, Rujia Fan, Fang Ren in Discover Oncology (2023)

  3. Article

    Open Access

    Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study

    Endometrial carcinoma (EC) is the second most common gynecological malignancy, and the differences between different pathological types are not entirely clear. Here, we retrospectively collected eligible EC pa...

    Gong Zhang, Fangfang Nie, Weinan Zhao, Pin Han in World Journal of Surgical Oncology (2023)

  4. Article

    Open Access

    The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation

    This study aimed to compare the survival outcome of 3 different treatment groups (arterial interventional chemotherapy or intravenous chemotherapy or concurrent chemoradiotherapy) for locally advanced cervical...

    Yi Sun, Gailing Li, Panpan Hai, Yuan Cao, Pin Han in World Journal of Surgical Oncology (2022)